Overview

Drug and Non-Drug Treatment Of Severe Migraine

Status:
Completed

Trial end date:
2005-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the addition of preventive medication, behavior migraine management or the combination of preventive medication and behavior migraine management improves the outcome of optimal acute therapy for frequent migraines.

Phase:

Phase 4

Details

Lead Sponsor:

Ohio University

Collaborators:

GlaxoSmithKline
Merck Sharp & Dohme Corp.
National Institute of Neurological Disorders and Stroke (NINDS)

Treatments:

Adrenergic beta-Antagonists
Nadolol
Propranolol